Spineart has launched a secured anterior cervical cage, the Scarlet AC-Ti, in the U.S.
Scarlet earned FDA clearance in May 2024, and has been evaluated in several clinical trials, according to a June 5 news release.
Zakhria Belasher, MD, a surgeon at Insight Surgical Hospital in Warren, Mich., has implanted more than 50 Scarlet AC-Ti devices so far.
The Scarlet AC-Ti builds on a decade of experience with the Scarlet system and utilizes its Ti-Life technology that provides a porous structure that closely mimics the trabecular bone structure.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
